| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |